Georgia Institute of Technology: NIH Awards $2.9M to Annoviant to Advance Heart Disease Technology
April 20, 2024
April 20, 2024
ATLANTA, Georgia, April 20 (TNSres) -- Georgia Institute of Technology issued the following news:
Annoviant Inc. a health technology company and member startup in the Center for MedTech Excellence at Georgia Tech's Enterprise Innovation Institute, is receiving a $2.99 million National Institutes of Health (NIH) grant to further scale the development and commercialization of its TxGuard(TM) pulmonary-valved conduit for pediatric heart disease.
The award follows two Phase . . .
Annoviant Inc. a health technology company and member startup in the Center for MedTech Excellence at Georgia Tech's Enterprise Innovation Institute, is receiving a $2.99 million National Institutes of Health (NIH) grant to further scale the development and commercialization of its TxGuard(TM) pulmonary-valved conduit for pediatric heart disease.
The award follows two Phase . . .